FdaApplication
ANDA 218282
Identifiers
- fda_app_no: ANDA218282
Properties
| Property | Value |
|---|---|
| applicant_name | EIRGEN PHARMA LTD |
| application_type | ANDA |
| approval_date | 2024-12-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 50MG | CAPSULE;ORAL |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 25MG | CAPSULE;ORAL |
2 products